Press Releases

Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly...

Honeywell Expedites Development and Production of Vital Vaccines and Medical Therapies with Fast Track Automation

Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to move from regulatory approval to full production in as little as two months depending on...

Takeda Announces Compelling Data from the Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS

Takeda Pharmaceutical Company Limited announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American Society of Clinical Oncology (ASCO) Annual Meeting and the virtual 25th European Hematology Association (EHA)...

FDA Approves Lilly’s Tauvid Imaging Agent to Help Diagnose Alzheimer’s Disease

There are two abnormal proteins associated with Alzheimer’s disease. The first is amyloid. The second is tau. Eli Lilly announced that the U.S. FDA approved its Tauvid, a radioactive diagnostic agent for PET imaging in Alzheimer’s patients. It is...

Medpharm: Our First Step Towards Manufacturing in the US

MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, has taken the first steps to expand its manufacturing capacity in the US to complement an existing manufacturing facility in the UK. MedPharm has obtained a facility...

LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as...

TraceLink Introduces New Agile Issue Management Solution

TraceLink, Inc., the leading digital platform company for the life science supply chain, unveiled Agile Issue Managementâ„¢, a network-based supply chain solution that enables companies to collaboratively identify, document and resolve disruptive supply chain issues to ensure the availability...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read